カテゴリ： GlobalData, 医療/バイオ

転移性移行性（尿路上皮）がん治療薬の世界市場：治験レビュー

◆英語タイトル：Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H2, 2019
◆商品コード：GDT20FB0075
◆発行会社（リサーチ会社）：GlobalData
◆発行日：2019年12月
◆ページ数：224
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥265,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥530,000見積依頼/購入/質問フォーム
Enterprisewide Price（複数事業所内共有可）USD7,500 ⇒換算￥795,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

 【レポートの概要】

Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Metastatic Transitional (Urothelial) Tract Cancer Global Clinical Trials Review, H2, 2019″ provides an overview of Metastatic Transitional (Urothelial) Tract Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Transitional (Urothelial) Tract Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Metastatic Transitional (Urothelial) Tract Cancer 31
Oct 01, 2019: Jounce Therapeutics to present Poster on Vopratelimab at the Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting 31
Sep 17, 2019: Seattle Genetics announces presentation of new clinical data from enfortumab vedotin at the European Society for Medical Oncology (ESMO) 2019 Congress 31
Clinical Trial Profile Snapshots 33
Appendix 225
Abbreviations 225
Definitions 225
Research Methodology 226
Secondary Research 226
About GlobalData 227
Contact Us 227
Disclaimer 227
Source 228

List of Tables
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Region, 2019* 8
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2019* 16
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2019* 19
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Phase, 2019* 22
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30

List of Figures
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, G7 Countries (%), 2019* 16
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Metastatic Transitional (Urothelial) Tract Cancer to Oncology Clinical Trials, E7 Countries (%), 2019* 19
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
Metastatic Transitional (Urothelial) Tract Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30
GlobalData Methodology 226

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[転移性移行性（尿路上皮）がん治療薬の世界市場：治験レビュー]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 転移性移行(尿路上皮)癌(Metastatic Transitional (Urothelial) Tract Cancer)：世界の治験レビュー2014（地域別/フェーズ別治験件数、主要企業/研究機関動向）
    GDCLT0837 / GlobalData / 2014年版 / 当調査レポートでは、世界における転移性移行(尿路上皮)癌(Metastatic Transitional (Urothelial) Tract Cancer) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。 ・イントロダクション 　　- 転移性移行(尿路上皮)癌(Metastatic Transitional...[Summary] GlobalData's clinical trial report, [Metastatic Transitional (Urothelial) Tract Cancer - Global Clinical Trials Review 2014] provides data on the Metastatic Transitional (Urothelial) Tract Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Transitional (Urothelial) Tract Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key...
  2. 転移性移行細胞癌(尿路上皮細胞癌)(Metastatic Transitional Cell Cancer (Urothelial Cell Cancer))：世界の治験レビュー2014（地域別/フェーズ別治験件数、主要企業/研究機関動向）
    GDCLT0838 / GlobalData / 2014年版 / 当調査レポートでは、世界における転移性移行細胞癌(尿路上皮細胞癌)(Metastatic Transitional Cell Cancer (Urothelial Cell Cancer)) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。 ・イントロダクション 　　-...[Summary] GlobalData's clinical trial report, [Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) - Global Clinical Trials Review 2014] provides data on the Metastatic Transitional Cell Cancer (Urothelial Cell Cancer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Transitional Cell Cancer (Urothelial Cell Cancer). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the...
  3. 膵臓がん治療薬の世界市場：治験レビュー
    GDT20FB0017 / GlobalData / 2019年7月 / ...Pancreatic cancer Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Pancreatic cancer Global Clinical Trials Review, H2, 2019" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
  4. 直腸がん治療薬の世界市場：治験レビュー
    GDT20FB0065 / GlobalData / 2019年12月 / ...Rectal Cancer Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2019" provides an overview of Rectal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Rectal Cancer Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  5. 膀胱がん治療薬の世界市場：治験レビュー
    GDT20FB0059 / GlobalData / 2019年12月 / ...Bladder Cancer Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2019" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  6. 腎臓がん（腎細胞がん）治療薬の世界市場：治験レビュー
    GDT20FB0101 / GlobalData / 2020年1月 / ...Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H1, 2020" provides an overview of Kidney Cancer (Renal Cell Cancer) Clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Cancer (Renal Cell Cancer). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
  7. 脳がん治療薬の世界市場：治験レビュー
    GDT20FB0126 / GlobalData / 2020年1月 / ...Brain Cancer Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Brain Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  8. 小細胞肺がん治療薬の世界市場：治験レビュー
    GDT20FB0103 / GlobalData / 2020年1月 / ...Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Small-Cell Lung Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Small-Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number...
  9. 甲状腺癌治療薬の世界市場：治験レビュー
    GDT20FB0095 / GlobalData / 2020年1月 / ...Thyroid Cancer Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Thyroid Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Thyroid Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  10. 悪性中皮腫治療薬の世界市場：治験レビュー
    GDT20FB0079 / GlobalData / 2019年12月 / ...Malignant Mesothelioma Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H2, 2019" provides an overview of Malignant Mesothelioma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Mesothelioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆